BAJAJ HEALTHCARE Latest Share Price (BAJAJHCARE)
TODAY IN ONE LINE
BAJAJHCARE fell 1.1% on above-average volume (1.9x avg), lagging Nifty's 0.1% move.
With a market cap of ₹1,086.63 Cr., it trades at a P/E of 55.51. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
BAJAJ HEALTHCARE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 58.6% skin-in-the-game
- ●Promoter BuyingPromoters increased holdings by 0.30% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 4.0%
- ●Rising Receivables vs SalesReceivables grew 28.4% outpacing sales growth of 14.6%
Latest BAJAJ HEALTHCARE News
What changed recently?
Recent events, corporate actions, and announcements.
BAJAJ HEALTHCARE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for BAJAJ HEALTHCARE, framed against the sector median so the premium or discount is obvious at a glance.
BAJAJ HEALTHCARE trades at a P/E of 55.51× and P/B of 2.02×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
BAJAJ HEALTHCARE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for BAJAJ HEALTHCARE — derived from the latest tape, not yesterday's close.
BAJAJ HEALTHCARE last traded at ₹321.45 with an intraday range of ₹319.85–₹331.9 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹321.45| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 353.05 | +31.60 | +9.83% |
| R3 | 341.00 | +19.55 | +6.08% |
| R2 | 336.45 | +15.00 | +4.67% |
| R1 | 328.95 | +7.50 | +2.33% |
| PIVOT | 324.40 | 2.95 | 0.92% |
| CURRENT | 321.45 | — | — |
| S1 | 316.90 | -4.55 | -1.42% |
| S2 | 312.35 | -9.10 | -2.83% |
| S3 | 304.85 | -16.60 | -5.16% |
| S4 | 292.80 | -28.65 | -8.91% |
BAJAJHCARE is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹324–₹331.9
Trading Below opening range, showing Bearishness
BAJAJ HEALTHCARE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for BAJAJ HEALTHCARE — consolidated or standalone — with margins, YoY growth and key ratios inline.
BAJAJ HEALTHCARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,086.63 Cr. and reported EPS of ₹4.07.
BAJAJ HEALTHCARE segment analysis : revenue and profit mix.
Disclosed business segments at BAJAJ HEALTHCARE with their share of revenue and profit, switchable between consolidated and standalone reporting.
BAJAJ HEALTHCARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for BAJAJ HEALTHCARE.
Our AI distills the core fundamental drivers supporting BAJAJ HEALTHCARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
BAJAJ HEALTHCARE's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Promoter holding 58.59% demonstrates strong long-term commitment and governance stability.
Operating margin 12.65% (TTM) shows decent operational efficiency relative to sector peers.
Debt-to-equity ratio 0.0044x ensures minimal financial leverage and balance sheet risk.
Operating cash flow ₹50.19 Cr (TTM) supports liquidity, dividend sustainability, and capex flexibility.
Latest quarterly PAT ₹13.7 Cr signals operational improvement and profit momentum.
Key Risks.
ROE 4.00% significantly lags peer median 11–18%, indicating weak capital efficiency.
ROCE 7.02% trails peer median 15–22%, suggesting limited competitive moat durability.
TTM revenue declined 0.9%, reflecting stagnant top-line growth and market headwinds.
Net profit margin 2.56% (TTM) is lowest among peers, compressing profitability and returns.
P/E 61.70x exceeds peer median, signaling expensive valuation despite weak fundamentals.
Flip Conditions.
Valuation risk. a P/E above 72 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
BAJAJ HEALTHCARE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — BAJAJ HEALTHCARE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
BAJAJ HEALTHCARE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for BAJAJ HEALTHCARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
BAJAJ HEALTHCARE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for BAJAJ HEALTHCARE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in BAJAJ HEALTHCARE stood at 46.1% of traded volume, against a 20-day average of 48.3%.
BAJAJ HEALTHCARE announcements: results, concalls, ratings, M&A.
Filings BAJAJ HEALTHCARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
BAJAJ HEALTHCARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 81 documents below.
Record Date
Bajaj Healthcare Limited has informed the Exchange that Record date for the purpose of Dividend is 14-Sep-2026.
Copy of Newspaper Publication
Bajaj Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
General Updates
Bajaj Healthcare Limited has informed the Exchange regarding the Inland Letters sent to Shareholders
General Updates
Bajaj Healthcare Limited has informed the Exchange regarding Business Responsibility and Sustainability Report for the financial year 2025-26
Shareholders meeting
Bajaj Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2026
Investor decks & rating reports.
BAJAJ HEALTHCARE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue BAJAJ HEALTHCARE has declared, sequenced by announce and record date.
BAJAJ HEALTHCARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
BAJAJ HEALTHCARE insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in BAJAJ HEALTHCARE as reported to SEBI — buying and selling signals from the people who know the business best.
BAJAJ HEALTHCARE insider activity below tracks 22 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| SAJANKUMAR RAMESHWARLAL BAJAJ | Insider | 18 Mar 2026 | buy | +4.55 L | ₹15.38 Cr. | ₹338.00 |
| ANIL CHAMPALAL JAIN | Insider | 18 Mar 2026 | buy | +4.55 L | ₹15.38 Cr. | ₹338.00 |
| SAJANKUMAR RAMESHWARLAL BAJAJ | Insider | 18 Mar 2026 | buy | +4.55 L | ₹15.38 Cr. | ₹338.00 |
| ANIL CHAMPALAL JAIN | Insider | 18 Mar 2026 | buy | +4.55 L | ₹15.38 Cr. | ₹338.00 |
| SAJANKUMAR RAMESHWARLAL BAJAJ | Insider | 18 Mar 2026 | buy | +4.55 L | ₹15.38 Cr. | ₹338.00 |
| ANIL CHAMPALAL JAIN | Insider | 18 Mar 2026 | buy | +4.55 L | ₹15.38 Cr. | ₹338.00 |
| ANIL CHAMPALAL JAIN | Insider | 18 Mar 2026 | buy | +4.55 L | ₹15.38 Cr. | ₹338.00 |
| SAJANKUMAR RAMESHWARLAL BAJAJ | Insider | 18 Mar 2026 | buy | +4.55 L | ₹15.38 Cr. | ₹338.00 |
| ANIL CHAMPALAL JAIN | Insider | 17 Mar 2026 | buy | +7.1 K | ₹19.91 L | ₹280.60 |
| ANIL CHAMPALAL JAIN | Insider | 17 Mar 2026 | buy | +7.1 K | ₹19.91 L | ₹280.60 |
About BAJAJ HEALTHCARE: business, sector, key facts.
What BAJAJ HEALTHCARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
BAJAJ HEALTHCARE operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: BAJAJHCARE, BSE: 539872.
Bajaj HealthCare Limited is an Indian pharmaceutical company established in 1993 and headquartered in Thane. Its core business revolves around the development, manufacturing, marketing, and sale of pharmaceutical products across India and internationally. Their offerings span a wide range, catering to the pharmaceutical, nutraceutical, and food industries.
A significant portion of their business involves the production and supply of active pharmaceutical ingredients (APIs). These APIs cover a broad spectrum of therapeutic categories, including treatments for diabetes, infections (antibiotic, antiviral, antifungal), cardiovascular issues, respiratory ailments (anti-asthmatic, bronchodilator), and many others. The extensive list of therapeutic areas indicates a diverse portfolio designed to meet varied market demands.
Beyond APIs, Bajaj HealthCare also manufactures and provides pharmaceutical intermediates. These are crucial chemical compounds used in the synthesis of APIs. The company's production of intermediates demonstrates vertical integration within the pharmaceutical supply chain, allowing for greater control over quality and potentially reducing costs.
Finally, Bajaj HealthCare produces finished dosage forms, offering a variety of formulations such as tablets, capsules, sachets, and vials. This provides a complete solution to customers, offering both the raw materials and the final products. The inclusion of nutraceuticals and food supplements further diversifies their product offerings and expands their market reach.
In summary, Bajaj HealthCare operates as a fully integrated pharmaceutical company, from the production of basic intermediates to the manufacturing and distribution of finished pharmaceutical and nutraceutical products. Their broad therapeutic coverage and diverse product portfolio position them within a competitive market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AAREY DRUGS & PHARM (AAREYDRUGS) Share PricePeer
- AARTI DRUGS (AARTIDRUGS) Share PricePeer
- AARTI PHARMALABS (AARTIPHARM) Share PricePeer
- AJANTA PHARMA (AJANTPHARM) Share PricePeer
- AKUMS DRUGS AND PHARMA L (AKUMS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about BAJAJ HEALTHCARE (BAJAJHCARE).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of BAJAJ HEALTHCARE (BAJAJHCARE)?
The current share price of BAJAJ HEALTHCARE (BAJAJHCARE) is ₹321.45. Today, the stock has declined by ₹3.75 (1.15%), trading in a range of ₹319.85 to ₹331.90. The stock opened at ₹327.80 with a trading volume of 4,58,849 shares.
02Is BAJAJ HEALTHCARE stock a good investment for long-term?
BAJAJ HEALTHCARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,086.63 Cr., P/E ratio of 55.51, ROE of 4%, and ROCE of 5.17%. The dividend yield stands at 0.31%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of BAJAJ HEALTHCARE stock?
The 52-week high price of BAJAJ HEALTHCARE (BAJAJHCARE) is ₹515.90, while the 52-week low is ₹272.35. Currently trading at ₹321.45, the stock is 18.03% above its 52-week low and 37.69% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy BAJAJ HEALTHCARE stock at the current price?
Whether to buy BAJAJ HEALTHCARE stock at ₹321.45 depends on multiple factors. The stock is currently trading with a P/E ratio of 55.51 and P/B ratio of 2.02. Today's performance shows a loss of 1.15%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of BAJAJ HEALTHCARE and when is the next dividend?
BAJAJ HEALTHCARE offers a dividend yield of 0.31%, which means for every ₹100 invested at the current price of ₹321.45, you can expect to receive approximately ₹0.31 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of BAJAJ HEALTHCARE?
BAJAJ HEALTHCARE's key financial metrics include: P/E Ratio: 55.51, P/B Ratio: 2.02, ROE: 4%, ROCE: 5.17%, Dividend Yield: 0.31%, EPS: ₹4.07, Book Value: ₹158.34, and Debt-to-Equity: 0.44. The company's market cap stands at ₹1,086.63 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is BAJAJ HEALTHCARE stock performing today in the market?
BAJAJ HEALTHCARE stock opened at ₹327.80 and is currently trading at ₹321.45, showing a decline of ₹3.75 (1.15%). The intraday high is ₹331.90 and low is ₹319.85. The trading volume stands at 4,58,849 shares, indicating moderate market participation today.
08What is the P/E ratio of BAJAJ HEALTHCARE and what does it indicate?
BAJAJ HEALTHCARE has a Price-to-Earnings (P/E) ratio of 55.51, which means investors are willing to pay 55.51 for every ₹1 of earnings. With an EPS of ₹4.07, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about BAJAJ HEALTHCARE (BAJAJHCARE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.